Development and reversibility of urolithiasis in rats by mineral mixtures.
D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D002118:Calcium / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002364:Caseins; D004044:Dietary Proteins; D004602:Elements / Q000009:adverse effects*; D007668:Kidney / Q000473:pathology; D007669:Kidney Calculi / Q000209:etiology; D008297:Male; D010710:Phosphates / Q000009:adverse effects* / Q000627:therapeutic use; D010758:Phosphorus / Q000008:administration & dosage; D051381:Rats; D012492:Salts / Q000009:adverse effects; D013997:Time Factors; D014514:Ureteral Calculi / Q000209:etiology; D001743:Urinary Bladder / Q000473:pathology; D001744:Urinary Bladder Calculi / Q000209:etiology; D014545:Urinary Calculi / Q000209:etiology* / Q000401:mortality / Q000473:pathology / Q000517:prevention & control
D002364:Caseins; D004044:Dietary Proteins; D004602:Elements; D010710:Phosphates; D012492:Salts; D010758:Phosphorus; D002118:Calcium